Top Health Tools
Top Health Tools

Top Reports
Top Reports
 
Top Articles
Top Articles

Top Reviews
Top Reviews
   
 
Approved H1N1 Vaccines Contain Ingredients Known to Cause Cancer and Death

Most health experts will agree that vaccine reactions can occur. It is estimated that roughly 1 in every million people will react to their vaccine. Even then, health officials maintain that it is usually a simple case of inflammation at the injection site and/or a slight fever. On a rare occasion, anaphylactic shock may occur due to the patient reacting to a substance that they are allergic to. However, the FDA recently approved four H1N1 vaccines that not only contain very questionable ingredients, but some of those ingredients have even been proven to cause cancer and death.

The FDA has awarded H1N1 contracts to the following companies: MedImmune, LLC (1), CSL Limited (2), Novartis Vaccines and Diagnostics Limited (3), and Sanofi Pasteur (4). Their package inserts became public knowledge in recent weeks.

All four vaccines list hypersensitivity to eggs as a contraindication (1) (2) (3) (4). This means that it is not advisable to administer any one of these products to a person suffering from a severe egg allergy or egg protein allergy. This contraindication may affect as many as 15 million people (based on a population of 300 million). (5). While parents are instructed not to feed their infant eggs until 1 year of age, these same infants will be exposed to eggs by way of their H1N1 vaccine and/or seasonal flu vaccine beginning at 6 months of age.

CSL’s vaccine (2) also lists hypersensitivity to chicken protein as a contraindication. “While most people who are sensitive to eggs can eat chicken, there is one protein that is present in both eggs and poultry — alpha-livetin, or chicken serum albumin — that can cause allergies to both foods.” (6) It is unknown at this time how many people are allergic to the aforementioned proteins. Going into anaphylactic shock is a very real possibly if one were to receive an ingredient that he/she is allergic to.

Neomycin and polymyxin are listed as contraindications for CSL’s (2) and Novartis’ (3) vaccines. “Neomycin may cause damage to the kidneys and/or nerves. Kidney function and drug levels in the blood may be monitored with blood tests during treatment. Tell your doctor if you experience decreased urination, hearing loss, ringing in the ears, feeling of fullness in the ears, dizziness, numbness, skin tingling, muscle twitching, or seizures which may be signs of kidney or nerve damage.” (7) According to Teva Pharmaceuticals, the effects of neomycin may not be evident until long after the medication has been discontinued. Just exactly how long is unclear at this time. (8) Polymyxin has its own set of possible adverse reactions. “Neurotoxic reactions may be manifested by irritability, weakness, drowsiness, ataxia, perioral paresthesia, numbness of the extremities, and blurring of vision. These are usually associated with high serum levels found in patients with impaired renal function and/or nephrotoxicity.” (9)

Gentamicin (10) is listed as a contraindication for MedImmune’s vaccine (1). It too, has its own list of possible side effects, which may include nephrotoxicity and/or neurotoxicity.

Nephrotoxicity is when damage or injury occurs to the kidneys as a result of taking certain medications. This may include kidney failure. (11) Neurotoxicity is when the damage involves the nerve tissue, such as paralysis or encephalitis (brain swelling). (12)

A word of caution to parents is warranted here: several vaccine manufacturers list crying or high-pitched screaming for greater than 3 hours as a sign of a serious vaccine reaction. Though this same warning is not applicable to any one of these H1N1 vaccines, it is still a situation that a parent should be alert to. If your child is crying or screaming for a long period of time, it may be a sign of brain inflammation. You know your child better than anyone. If something doesn’t feel right, have your child evaluated immediately.

It is very important to note that administration of more than one aminoglycoside, such as neomycin, polymyxin, or gentamicin, is not advisable. In fact, it is even listed as a major drug interaction. (13) One can only imagine what could happen if a healthcare professional were to administer an H1N1 vaccine in conjunction with a seasonal flu vaccine or any other vaccines on the same day. Fluarix (14) and Flumist (15) are two U.S. licensed seasonal flu vaccines on the market today that both contain gentamicin sulfate. Common childhood vaccines, Pediatrix (16) and Pentacel (17) contain neomycin and polymyxin b sulfate. Furthermore, when aminoglycosides are administered with any other drugs or chemicals that alter kidney function, the toxicity is far greater, as well as the risk of having complications, such as ototoxicity (ear poisoning). (18) Other medications that may alter kidney function include non-steroidal anti-inflammatory drugs (such as ibuprofen or naproxen) or cholesterol lowering medications. (19) Non-steroidal anti-inflammatory drugs are also found in many cold and allergy preparations as well. (20)

Gelatin is listed as a contraindication for Sanofi Pasteur’s (1) and MedImmune’s (4) vaccines. A severe allergy to this ingredient is estimated to be present in about 1 in every 2 million doses. (21) Food sources may include jams, yogurt, cream cheese, margarine, ice cream, etc. It would be wise to review the patient’s history prior to the administration of any vaccines containing gelatin.

Arginine and asthma are both listed as contraindications for MedImmune’s vaccine. (1) Apparently, if the patient is suffering from hyperargininemia (elevated arginine levels), this ingredient should be avoided. (22) This metabolic disorder is estimated to affect 1 in every 300,000 babies born in the United States. (23) The vaccine is also not advisable for persons suffering from asthma because it may worsen symptoms. (1) Asthma, by the way, currently affects 20 million people in the U.S. alone and is sharply on the rise. (24)

The method of dosing is quite confusing in my opinion. In certain situations, a toddler will receive twice the amount of vaccine than an adult would. For example, MedImmune calls for a 2 year old child to receive 2 doses of 0.2 mL each, approximately 1 month apart, while an adult will simply receive 1 dose of 0.2 mL. Sanofi Pasteur instructs the medical professional to administer 2 doses of 0.5 mL 1 month apart to children 36 months through 9 years of age, while an adult will only receive 1 dose of 0.5 mL. (1) (4)

An overview of the remaining chemicals may prove to be further unsettling. Sanofi Pasteur’s vaccine (4) also contains formaldehyde (25), which is a suspected carcinogen (cancer-causing), Triton X-100 (26), which is possibly a reproductive toxin, and thimerosal (27), which is mutagenic for mammalian somatic cells (alters DNA).

MedImmune’s vaccine (1) also contains monosodium glutamate (MSG), dibasic potassium phosphate (28), and monobasic potassium phosphate (29). Because so many people are sensitive to MSG, oriental restaurants have taken it upon themselves to serve and advertise food completely free of it! The other two ingredients, dibasic potassium phosphate and monobasic potassium phosphate may be harmful if swallowed or inhaled. They will also be present in CSL’s vaccine (2).

Potassium chloride (30), calcium chloride (31), and sodium chloride (32) are also listed as ingredients for CSL. All three are considered mutagenic for mammalian somatic cells. By far, the most disturbing ingredient of all is that which is found in both CSL (2) and Novartis’ (3) vaccines – beta-propiolactone (33). It is a proven carcinogen by OSHA and is toxic to kidneys, lungs, liver, and digestive system. It is also corrosive to skin and eyes on contact. Then of course, there is the monobasic sodium phosphate (34) and sodium taurodeoxycholate (35) to contend with. Both are considered “slightly hazardous” in cases of contact with skin, eyes, ingestion, or inhalation.

During the clinical trials conducted by the makers of said products (1) (2) (3) (4), it was noted that the following reactions occurred: headache, nasal congestion, cough, rhinorrhea, pharyngolaryngeal pain, reactogenicity event, diarrhea, back pain, upper respiratory tract infection, viral infection, lower respiratory tract infection, myalgia, and muscle spasm. Once the products were released onto the market, the following unsolicited adverse events occurred: dizziness, nausea, vomiting, diarrhea, transient thrombocytopenia, lymphadenopathy, anaphylactic shock, serum sickness, neuralgia, paresthesia, convulsions, encephalopathy, neuritis or neuropathy, transverse myelitis, Guillian-Barre syndrome, vasculitis with transient renal involvement, pruritis, uticaria, rash, influenza-like illness, Stevens-Johnson syndrome, Epistaxis, and brachial neuritis. However, due to the unknown number of people reporting these events, it is not possible to determine whether or not these events occurred due to the vaccine administered.

Don’t be alarmed folks by all of this medical and chemical jargon. It is not known at this time whether or not these vaccines (1) (2) (3) (4) can cause carcinogenesis (cancer), mutagenesis (alter your DNA) or impairment of fertility because the studies have not been performed.

This disclaimer may be found on all 4 vaccine package inserts in Section 13.1 titled “Carcinogenesis, Mutagenesis, Impairment of Fertility.”

(1) ,
(2) , (3) , (4) , (5) , (6) , (7) , (8) , (9) , (10) , (11) , (12) , (13) , (14) , (15) (16) , (17) , (18) , (19) , (20) , (21) , (22) , (23) , (24) , (25) , (26) , (27) , (28) (29) , (30) , (31) , (32) , (33) , (34) , (35)

SUSTAINABLE FUTURES INTERVIEW:
The Truth About the H1N1 Vaccine
Part 1








Part 2








Part 3








Part 4








Part 5








Part 6








Part 7








Email with any reports or comments regarding the flu pandemic in your area.


Reference Source 237
October 2, 2009
Share/Bookmark
...............................................................................................................

This site is owned and operated by PreventDisease.com 1999-2014. All Rights Reserved. All content on this site may be copied, without permission, whether reproduced digitally or in print, provided copyright, reference and source information are intact and use is strictly for not-for-profit purposes. Please review our copyright policy for full details.
aaa
Interact
volunteerDonateWrite For Us
Stay Connected With Our Newsletter